EMUSURVE Trademark

Trademark Overview


On Wednesday, August 17, 2022, a trademark application was filed for EMUSURVE with the United States Patent and Trademark Office. The USPTO has given the EMUSURVE trademark a serial number of 97552709. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 26, 2024. This trademark is owned by Pfizer Inc.. The EMUSURVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of ulcerative colitis, Crohn's disease, alopecia, irritable bowel syndrome and dermatological diseases and disorders
emusurve

General Information


Serial Number97552709
Word MarkEMUSURVE
Filing DateWednesday, August 17, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of ulcerative colitis, Crohn's disease, alopecia, irritable bowel syndrome and dermatological diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, February 26, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 26, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023ASSIGNED TO EXAMINER
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 20, 2022NEW APPLICATION ENTERED